A number of studies have evaluated atherosclerosis risk associated with complement activation in mice on different atherosclerosis-prone backgrounds, including apolipoprotein E knockout (apoE−/−), LDL receptor knockout, LDLR−/−, and combined apoE−/− LDLR−/− mice. This evidence concerns the gene APOE and atherosclerosis.